EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Chemotherapy of Trypanosome and Spirochete Infections : Biological Series. Iii. the Therapeutic Action of N-Phenylglycineamide-P-Arsonic Acid in Experimental Trypanosomiasis of Rabbits


Chemotherapy of Trypanosome and Spirochete Infections : Biological Series. Iii. the Therapeutic Action of N-Phenylglycineamide-P-Arsonic Acid in Experimental Trypanosomiasis of Rabbits



Journal of Experimental Medicine 30(5): 455-481



ISSN/ISBN: 0022-1007

PMID: 19868371

DOI: 10.1084/jem.30.5.455

In the treatment of experimental trypanosomiasis of rabbits with subsequent appraisal of the value of the therapeutic agent used, there are certain experimental factors including uniform infecting strains of trypanosomes and the observation of general procedures of method and time of inoculation conditioned by the infection itself which must be taken into account. The conspicuous and characteristic clinical signs and symptoms seen in rabbit trypanosomiasis serve as criteria of the severity and duration of the disease, and it is obvious that the infection should be well established before treatment is instituted. For the same reason, before the question of a permanent cure can be established, treated rabbits should be kept under observation for a sufficient period of time, which with the species of organisms that we have used is at least 3 months. The therapeutic results with the amide of N-phenylglycine-p-arsonic acid were obtained in rabbits which showed well marked clinical signs of a definitely established disease, and in many instances the infection was extremely advanced and of prolonged duration. The five species which we have employed, Tr. brucei, Tr.gambiense, Tr. equinum, Tr. equiperdum, and Tr. evansi, are uniformly fatal in rabbits. With the usual acute, actively progressing infection of from I to 2 weeks duration produced by our strain of Tr. brucei, the drug has a curative range of from 0.2 to 0.35 gm. per kilo of body weight, when administered intravenously in single doses, or from one-third to one-half the minimal lethal dose. Of the twenty-nine rabbits treated with doses falling within this range, twenty-five, or 86 per cent, were permanently cured and there were no relapses observed with doses above 0.3 gm. The infection produced by our strain of Tr. gambiense is controlled by a slightly lower dose, since there were no relapses with single doses of 0.3 gm. and a single dose of 0.15 gm. effected a cure in one of three rabbits so treated. The therapeutic experiments with Tr. equinum, Tr. equiperdum, and Tr. evansi are too few to admit of final conclusions, but apparently from the evidence at hand, much the same curative range is operative in Tr. evansi infections, while larger doses or a different system of treatment should have been employed in the treatment of rabbits infected with our strains of Tr. equinum and Tr. equiperdum. In addition to the ultimate curative results obtained with single doses within the curative range, it is important to consider the marked therapeutic action with smaller single doses, as shown by the rapid regression and healing of the clinical lesions of the acute infections produced by all five species of trypanosomes together with a marked improvement in the general physical state of the animal. Moreover, large single doses, above those of the so called curative range, caused no disturbance of a toxic nature and were apparently well borne. A system of repeated dose therapy may be employed with advantage in the treatment of both initial and relapsed infections in rabbits, especially in those instances in which there is induration or even necrosis of tissues with weakness and emaciation of the animal host. The factor of time of repetition or the spacing of doses is in our experience as important as that of size of the dose employed and depends upon the rate, degree, and duration of action of the particular dose of the drug in question. Since the amide of N-phenylglycine-p-arsonic add apparently possesses the power of tissue penetration to a marked degree, it is desirable to give the second dose within a short time after the first in order that it may have a full opportunity for the immediate and complete development of its action. The repetition of small doses such as 0.15 gm. per kilo of body weight on successive or alternate days has given successful results as regards both the immediate regression and healing of lesions and ultimate permanent cures in severe, chronic infections. It is possible, however, to administer increasingly large doses, if this is necessary, since infected as well as normal rabbits exhibit a remarkable tolerance to repeated large doses of the drug. The therapeutic activity of small doses administered intramuscularly is quite comparable with that observed after similar doses given intravenously, as indicated by the rate of regression and healing of clinical lesions, while such effects proceed somewhat more slowly after subcutaneous injections. Permanent cures have been obtained in Tr. brucei infection with intramuscular and subcutaneous administration of single doses of from 0.2 to 0.5 gm. of the drug per kilo of body weight and in other instances with three repeated doses of 0.1 gm. per kilo given intramuscularly. One severely infected rabbit which received 0.75 gm. per kilo per os immediately following a small dose of sodium bicarbonate was also cured. The therapeutic experiments here reported represent only a portion of those carried out with N-phenylglycineamide-p-arsonic acid and the scope of the present paper does not permit a detailed description of the many phases of the experiments or a full discussion of the various factors involved and the results obtained, all of which we hope to publish at some future time.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051892922

Download citation: RISBibTeXText

Related references

Chemotherapy of Trypanosome and Spirochete Infections : Biological Series. Ii. The Therapeutic Action of N-Phenylglycineamide-P-Arsonic Acid in Experimental Trypanosomiasis of Mice, Rats, and Guinea Pigs. Journal of Experimental Medicine 30(5): 437-453, 1919

Chemotherapy of Trypanosome and Spirochete Infections : Biological Series. Iv. the Action of N-Phenylglycineamide-P-Arsonic Acid upon Spirochete Infections. Journal of Experimental Medicine 30(5): 483-496, 1919

Chemotherapy of Trypanosome and Spirochete Infections : Biological Series. I. the Toxic Action of N-Phenylglycineamide-P-Arsonic Acid. Journal of Experimental Medicine 30(5): 417-436, 1919

Biological Series. III. The Therapeutic Action of N-Phenylglycineamide-p-Arsonic Acid in Experimental Trypanosomiasis of Rabbits. Jl. Exper. Med 30(5): 455-481, 1919

Chemotherapy of Trypanosome and Spirochete Infections : Chemical Series. I. N-Phenylglycineamide-P-Arsonic Acid. Journal of Experimental Medicine 30(5): 411-415, 1919

Biological Series IV. The Action of N-Phenylglycineamide-y-Arsonic Acid upon Spirochete Infections. Jl. Exper. Med 30(5): 483-496, 1919

Biological Series. II. The Therapeutic Action of N-Phenylglycineamide-p-Arsonic Acid in Experimental Trypanosomiasis of Mice, Rats, and Guinea Pigs. Jl. Exper. Med 30(5): 437-453, 1919

Therapeutic Action of N-Phenylglycineamide-P-Arsonic Acid (Tryparsamide) upon Experimental Infections of Trypanosoma Rhodesiense. Journal of Experimental Medicine 33(2): 193-200, 1921

Biological Series. I. The Toxic Action of N-Phenylglycineamide-p-Arsonic Acid. Jl. Exper. Med 30(5): 417-436, 1919

Studies on the Treatment of Human Trypanosomiasis with Tryparsamide (The Sodium Salt of N-Phenylglycineamide-P-Arsonic Acid). Journal of Experimental Medicine 34(6 Suppl 1: 1-104, 1921

Immunity in spirochete and trypanosome infections. Seuchen Bekampfung 5(3): 160-166, 1928

Evolution of different antibodies during experimental trypanosome infections in rabbits.. Rev. Jmmunol 26: 157-166, 1962

Toxicity, therapeutic activity, and mode of action of sulfanilamide in experimental streptococcus infections of rabbits. Jour Lab And Clin Med 24(2): 164-177, 1938

The Derivatives of Phenylarsenic Acid in the Treatment of Experimental Trypanosomiasis and Spirilloses. The Relationship between the Therapeutic Action of the Aromatic Arsenic Acids and their Constitution. Rev. Gen. Med. Vet 37(6): 551-617, 1923

The curative therapeutic effect of diamidinodiphenoxypentane on experimental infection with Trypanosoma gambiense of the rat. II. the behavior of animals previously cured of trypanosomiasis by the delayed inoculation of the homologous trypanosome. Bulletin de la Societe de Pathologie Exotique et de Ses Filiales 45(3): 321-326, 1952